# InnovAge Holding Corp. (INNV) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Health Care Providers. Price $8.85, market value $1.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). InnovAge Holding Corp. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.19**. A PEG of 0.19 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.2×**. Each dollar of revenue is priced at 1.2×.
- **Price / book: 5.1×**. The shares trade at 5.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 48.7×**. Enterprise value is 48.7× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 4.2%** (5-yr avg -0.1%). Free cash flow equals 4.2% of the market value, above its five-year average of -0.1%, so the shares are cheaper on cash than they have usually been.

## Profitability
- **Gross margin: 23.0%**. InnovAge Holding Corp. keeps 23.0% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 0.3%**. 0.3% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -0.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -1.1%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 1.1%**. Return on all capital, debt included, is 1.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -0.5%**. Each dollar of assets produces -0.5% of profit.

## Growth
- **Revenue growth (1 yr): 15.9%** (3-yr 12.9%/yr, 5-yr 9.2%/yr). Revenue grew 15.9% over the last year, against 9.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 90.9%**. Earnings per share rose 90.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.20**. Debt is 0.20 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. InnovAge Holding Corp. holds more cash than debt.
- **Current ratio: 1.05** (quick 1.05). Current assets cover the next year's liabilities 1.05 times.
- **Altman Z-score: 4.92**. A Z-score of 4.92 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. InnovAge Holding Corp. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 98.7%** (YTD 71.9%, 3-mo -20.6%). The shares are up 98.7% over twelve months including dividends.
- **From 52-week high: -30.0%** (124.9% above the low). Trading 30% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 40**. An RSI of 40 is neutral.
- **Beta (1 yr): 0.75** (volatility 75%). Beta of 0.75 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=INNV · Page: https://foliofundamentals.com/stocks/innv

Not investment advice.